Estée Lauder Companies' (EL) fiscal 2026 third quarter earnings, covering January through March, arrive as part of its "Beauty Reimagined" turnaround strategy. From what I see, after a tough stretch with weak demand in China and travel retail, the Q2 results marked real progress—organic net sales grew 4%, fueled by skincare and fragrance. This report matters because it will shed light on cost-cutting efforts, including up to 7,000 job reductions, and margin improvements. For investors like us, it's a key check on whether prestige beauty demand is recovering, particularly in Asia, against a backdrop of economic uncertainty and tariff risks. Solid execution here could solidify the raised full-year outlook, but any hiccups might add pressure to shares that are already down over 25% year-to-date.
Wall Street looks for Q3 revenue of $3.69 billion, up 3.91% year-over-year per 16 analysts. The EPS consensus is $0.65 from 19 analysts, suggesting stability from last year. I'll be paying close attention to organic net sales growth, projected in the low-single-digits for the second half, and adjusted operating margins, which are expected to dip about 50 basis points from investments and tariffs. I also checked this using Tickeron’s AI Screener to gauge how EL stacks up against peers.
The backdrop from recent quarters is encouraging but mixed: Q2 net sales hit $4.23 billion (up 6%) with adjusted EPS of $0.89, topping estimates and leading to raised FY2026 guidance of 1%-3% organic sales growth and $2.05-$2.25 adjusted EPS. Q1 also beat on revenue and earnings. That said, EL shares have a history of dropping after earnings—down following 10 of the last 12 reports—highlighting the market's emphasis on guidance and trends like China.
One tool I use regularly in my analysis is Tickeron’s AI Screener. It's an AI-powered platform for discovering stocks and ETFs by filtering on technical patterns, fundamentals, trends, volatility, and AI signals. I appreciate how it lets me scan thousands of names with custom filters like industry, market cap, indicators, and performance metrics to spot trade ideas, breakouts, or opportunities in sectors like consumer goods—saving time over manual work.
Sentiment heading into earnings feels cautiously optimistic after Q2's strong showing, though tariff concerns and ongoing China/travel retail issues temper expectations. Implied volatility points to an 8-10% potential move post-report, consistent with history where shares fell after 10 of 12 prior earnings. Risks like weaker Asia Pacific sales or cautious guidance could weigh on the stock, but skincare beats and upbeat China updates might drive a rebound. EL is trading around $77, well off its highs amid prestige beauty sector strains.
Keep an eye on any tweaks to FY2026 guidance: 1%-3% organic net sales growth and $2.05-$2.25 adjusted EPS, plus $1.1-$1.2 billion in operating cash flow. Updates here will show how "Beauty Reimagined" is tracking.
Mainland China is crucial—Q2 saw double-digit retail sales growth, but full-year projections are mid-single-digits. Momentum in skincare (up 6% organically in Q2) and fragrance, despite Northern Asia travel retail weakness, will be telling.
Cost controls remain essential amid restructuring for efficiency and tariff hits of about $100 million (mostly second half), which could squeeze margins. Track adjusted operating margins (9.8%-10.2% full-year target) and inventory for demand clues. Broader items like Q4 holidays, peer results, analyst days, or M&A could influence the story around a sustainable recovery. I'm watching this closely.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The 10-day RSI Oscillator for EL moved out of overbought territory on August 31, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 instances where the indicator moved out of the overbought zone. In 24 of the 29 cases the stock moved lower in the days that followed. This puts the odds of a move down at 83%.
The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EL as a result. In 65 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for EL turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 38 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
EL moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for EL entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The 50-day moving average for EL moved above the 200-day moving average on September 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where EL advanced for three days, in 187 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
EL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. EL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.083) is normal, around the industry mean (18.044). EL's P/E Ratio (191.140) is considerably higher than the industry average of (43.673). Projected Growth (PEG Ratio) (2.121) is also within normal values, averaging (1.518). Dividend Yield (0.015) settles around the average of (0.024) among similar stocks. P/S Ratio (2.317) is also within normal values, averaging (1.931).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which offers skin care, makeup, fragrance and hair care products
Industry HouseholdPersonalCare